Answers are grounded in this paper and cite their sources.
Case report demonstrates reversible erythroid hypoplasia and erythroblast vacuolization in a child with Brown–Vialetto–Van Laere syndrome 2, highlighting the diagnostic value of bone marrow...
To the Editor: Due to mammalian cells’ inability to synthesize riboflavin/vitamin B2, efficient uptake of this vitamin via its transport system is essential to the maintenance of riboflavin homeostasis, particularly in the central nervous system. Brown–Vialetto–Van Laere syndrome 2 (BVVLS2), also known as vitamin B2/riboflavin transporter deficiency, impairs cellular uptake of this water-soluble vitamin.1, 2 Prompt and accurate diagnosis of BVVLS2 is essential to avoid the onset of hematological and neurological impairments. Herein, we detail the case of a 4.5-year-old male with marked erythroid hypoplasia, who was misdiagnosed with Diamond Blackfan anemia for 3.5 years. After 3.5 years without initial symptom resolution and with the onset of additional neurological symptoms, genetic screening was performed to assess for genes associated with neuromuscular disorders, and mutations in the solute carrier family 52 member 2 (SLC52A2) gene were found. Upon retrospective review of a bone marrow smear taken years prior, vacuolation in erythroid precursors was clearly observed, accompanied by marked erythroid hypoplasia. This case highlights the critical importance of the combination of severe erythroid hypoplasia with erythroblast vacuolization morphological investigation to enable prompt and accurate diagnosis of this rare disease. In May 2018, an 11-month-old male patient was admitted to the clinic with severe anemia that had been present since birth. Initial hematological data showed severe normochromic anemia, including a hemoglobin concentration of 43 g/L, a mean corpuscular volume of 88.7 fL (82–96 fL) and a reticulocyte count of 11 × 109/L (17–70 × 109/L). Additional hematological results revealed a total leukocyte count of 13.4 × 109/L (5–12 × 109/L), neutrophil content of 6.3 × 109/L (0.8–4 × 109/L), a platelet count of 596 × 109/L (100–300 × 109/L), and red blood cell distribution width-corpuscular volume (RDW-CV) of 17.3% (0%–15%). The patient's serum levels of iron, folic acid, vitamin B12, holotranscobalamin, methylmalonic acid, and zinc were all within normal limits. Bone marrow aspiration was performed and demonstrated hyporegenerative anemia, and erythroid hypoplasia was characterized by visualization of vacuolation in erythroid precursors(Figure 1A). The patient's blood samples were then sent to a reference laboratory to be screened for common genetic mutations associated with anemia; however, no pathogenic mutation was found. It was reasoned at the time that the most apt diagnosis could be Diamond Blackfan anemia, given 15%–20% of cases display no currently known genetic etiologies.3 When subsequent prednisolone treatment proved ineffective, however, multiple blood transfusions were required to improve the severity of the anemia, though its underlying cause remained unknown. In December 2020, this same patient, now 4.5 years old, presented to the neurology department of a different children's hospital with an inability to climb or stand on his own, and had become prone to falling on his back and sides when seated in a chair. Physical examination showed he had reduced muscle tone in four limbs, and deep tendon reflexes were absent bilaterally at the knees. Next-generation sequencing was performed to screen for neuromuscular disorders and this identified two heterozygous variants in the SLC52A2 gene (c.350T>C, p.Leu117Pro and c.1135_1137delTGG, p.W379del). It was later identified that the patient's mother was a heterozygous carrier of a c.350T>C mutation, and his father a carrier of a c.1135_1137delTGG mutation within the SLC52A2 gene. Further SIFT prediction tool analysis indicated that the c.350T>C (p.Leu117Pro) was detrimental. These genetic variants once again implicated BVVLS2 as the underlying pathology responsible for this patient's symptoms. BVVLS2, also known as riboflavin transporter deficiency, is a rare neurodegenerative disorder and can be difficult to diagnose. Riboflavin has important antioxidant properties, and in the nervous system, riboflavin is essential for the synthesis of myelin. The resulting riboflavin deficiency that occurs from BVVLS2 can cause disruption of the myelin lamellae, which subsequently manifests as neurological deficits like those observed in the case presented herein.4 This diagnosis was further supported given riboflavin transporter deficiency's known etiology includes underlying biallelic pathogenic variants.5 The diagnosis of BVVLS2 was indeed finally confirmed to be correct when after receiving riboflavin supplementation (20–30 mg/day) for 2 months, the patient's hemoglobin increased to 139 g/L and his motor and muscle weakness symptoms began to improve. A 3-month follow-up bone marrow aspiration found that previously observed erythroid hypoplasia and vacuolation in erythroid precursors had disappeared and erythroblasts were easily observed (Figure 1B). After 2 years of vitamin B2 supplementation, this same patient today, now 6 years old, can finally walk, though not yet run, on his own. Follow-up physical examination demonstrated a return of this patient's deep tendon reflexes bilaterally at the knees. Thus, in this rare BVVLS2 case, the male was misdiagnosed with Diamond Blackfan anemia for 3.5 years, received unnecessary treatment courses, and developed severe neuromuscular symptoms that impaired physical development, all of which were avoidable. Previous reports found that the most common symptoms of BVVLS2 patients were hearing loss, followed by muscle weakness, visual impairment, and ataxia, though anemia was not a common observation.2 But riboflavin did play a role in erythropoiesis and enhance iron absorption.1, 6, 7 Riboflavin deficiency can interfere with iron utilization and impair the hemoglobin synthesis, and inadequate riboflavin intake was associated with an increased risk of persistent anemia.6 Thus, the riboflavin supplementation did improve the anemia in this male. Furthermore, in anemic presentations of BVVLS2, we contend that observed combinations of normocytic anemia and severe erythroid hypoplasia with erythroid vacuolization should prompt healthcare providers to carefully review bone marrow film morphology. Specifically, morphological notations of severe erythroid hypoplasia with erythroblast vacuolization can provide important clues to clinicians to consider BVVLS2 when considering the differential diagnosis of Diamond Blackfan anemia. Also, vitamin profiles were not examined, which resulted in the initial misdiagnosis in this patient. We additionally suggest whole-exome genomic sequencing may be shrewd to guide accurate diagnosis. Given how easily riboflavin therapy can remedy hematological and neurological impairments in individuals suffering from BVVLS2, prompt and accurate diagnosis is crucial to avoid the onset of severe neurological symptoms. Ke Cao and Meizhu Luo provided the images and clinical data, and guided the clinical diagnosis. Jiwei Zhao participated in data analysis. Yanxia Chen participated in data analysis and manuscript construction. Patrick McLinden participated in manuscript construction and revision. Jinlin liu designed the study, guided the clinical diagnosis, and co-wrote the manuscript. The authors declare they have no conflicts of interest. Zhejiang Provincial Natural Science Fund, Grant/Award Number: LY20H100008; Guangdong Basic and Applied Basic Research Foundation, Grant/Award Number: 2021A1515220072; Guangdong High-Level Hospital Construction Fund, and Science and Technology Project from the Science Technology and Innovation Committee of Shenzhen Municipality, Grant/Award Number: JCYJ20220530155811025.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: